PropertyValue
?:abstract
  • To date over 36 million people have been infected with the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19). While the vast majority will survive, many may be left with residual effects. Acute neurologic symptoms including encephalitis, acute myopathic quadriplegia, strokes and seizures have been reported in COVID-19.1 Anecdotally, even survivors without acute neurologic conditions have reported long-term neurologic symptoms months after their illness. These reports have called for the importance of studying long-term neurologic outcomes, also referred as the \'Long-Haul COVID\'.2 During previous epidemics, including SARS and MERS, both short- and long-term neurological symptoms were reported3 but the chronic neurological symptoms of COVID-19 are unknown. To characterize long-term neurologic outcomes after COVID-19 we followed a cohort of hospitalized patients and assessed 3-months outcomes.
is ?:annotates of
?:creator
?:doi
  • 10.1101/2020.10.16.20211029
?:doi
?:license
  • medrxiv
?:pdf_json_files
  • document_parses/pdf_json/d4be2c6eca5598b397a9fd0ace8ed60ff3e6bab1.json
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • MedRxiv; WHO
?:title
  • Three-month outcomes in hospitalized COVID-19 patients
?:type
?:year
  • 2020-10-18

Metadata

Anon_0  
expand all